Your browser doesn't support javascript.
loading
Exogenous hormone use, reproductive factors and risk of intrahepatic cholangiocarcinoma among women: results from cohort studies in the Liver Cancer Pooling Project and the UK Biobank.
Petrick, Jessica L; McMenamin, Úna C; Zhang, Xuehong; Zeleniuch-Jacquotte, Anne; Wactawski-Wende, Jean; Simon, Tracey G; Sinha, Rashmi; Sesso, Howard D; Schairer, Catherine; Rosenberg, Lynn; Rohan, Thomas E; Robien, Kim; Purdue, Mark P; Poynter, Jenny N; Palmer, Julie R; Lu, Yunxia; Linet, Martha S; Liao, Linda M; Lee, I-Min; Koshiol, Jill; Kitahara, Cari M; Kirsh, Victoria A; Hofmann, Jonathan N; Graubard, Barry I; Giovannucci, Edward; Gaziano, J Michael; Gapstur, Susan M; Freedman, Neal D; Florio, Andrea A; Chong, Dawn Q; Chen, Yu; Chan, Andrew T; Buring, Julie E; Freeman, Laura E Beane; Bea, Jennifer W; Cardwell, Christopher R; Campbell, Peter T; McGlynn, Katherine A.
  • Petrick JL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. jpetrick@bu.edu.
  • McMenamin ÚC; Slone Epidemiology Center, Boston University, Boston, MA, USA. jpetrick@bu.edu.
  • Zhang X; Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • Zeleniuch-Jacquotte A; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Wactawski-Wende J; Department of Population Health, New York University School of Medicine, New York, NY, USA.
  • Simon TG; NYU Perlmutter Cancer Center, New York University School of Medicine, New York, NY, USA.
  • Sinha R; Department of Epidemiology and Environmental Health, University at Buffalo, Buffalo, NY, USA.
  • Sesso HD; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Schairer C; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Rosenberg L; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Rohan TE; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Robien K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Purdue MP; Slone Epidemiology Center, Boston University, Boston, MA, USA.
  • Poynter JN; Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Palmer JR; Department of Exercise and Nutrition Sciences, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.
  • Lu Y; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Linet MS; Division of Pediatric Epidemiology and Clinical Research and Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  • Liao LM; Slone Epidemiology Center, Boston University, Boston, MA, USA.
  • Lee IM; Department of Population Health and Disease Prevention, Program in Public Health, University of California, Irvine, Irvine, CA, USA.
  • Koshiol J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Kitahara CM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Kirsh VA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Hofmann JN; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Graubard BI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Giovannucci E; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Gaziano JM; Epidemiology Division, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Gapstur SM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Freedman ND; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Florio AA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Chong DQ; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Chen Y; VA Boston Healthcare System, Boston, MA, USA.
  • Chan AT; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA.
  • Buring JE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Freeman LEB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Bea JW; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
  • Cardwell CR; Department of Population Health, New York University School of Medicine, New York, NY, USA.
  • Campbell PT; Department of Environmental Medicine, New York University School of Medicine, New York, NY, USA.
  • McGlynn KA; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Br J Cancer ; 123(2): 316-324, 2020 07.
Article en En | MEDLINE | ID: mdl-32376888
ABSTRACT

BACKGROUND:

Intrahepatic cholangiocarcinoma (ICC) arises from cholangiocytes in the intrahepatic bile duct and is the second most common type of liver cancer. Cholangiocytes express both oestrogen receptor-α and -ß, and oestrogens positively modulate cholangiocyte proliferation. Studies in women and men have reported higher circulating oestradiol is associated with increased ICC risk, further supporting a hormonal aetiology. However, no observational studies have examined the associations between exogenous hormone use and reproductive factors, as proxies of endogenous hormone levels, and risk of ICC.

METHODS:

We harmonised data from 1,107,498 women who enroled in 12 North American-based cohort studies (in the Liver Cancer Pooling Project, LCPP) and the UK Biobank between 1980-1998 and 2006-2010, respectively. Cox proportional hazards regression models were used to generate hazard ratios (HR) and 95% confidence internals (CI). Then, meta-analytic techniques were used to combine the estimates from the LCPP (n = 180 cases) and the UK Biobank (n = 57 cases).

RESULTS:

Hysterectomy was associated with a doubling of ICC risk (HR = 1.98, 95% CI 1.27-3.09), compared to women aged 50-54 at natural menopause. Long-term oral contraceptive use (9+ years) was associated with a 62% increased ICC risk (HR = 1.62, 95% CI 1.03-2.55). There was no association between ICC risk and other exogenous hormone use or reproductive factors.

CONCLUSIONS:

This study suggests that hysterectomy and long-term oral contraceptive use may be associated with an increased ICC risk.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Colangiocarcinoma / Anticonceptivos Hormonales Orales / Hormonas / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Aged / Female / Humans / Middle aged País como asunto: Europa Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Colangiocarcinoma / Anticonceptivos Hormonales Orales / Hormonas / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Aged / Female / Humans / Middle aged País como asunto: Europa Idioma: En Año: 2020 Tipo del documento: Article